Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Debt to Equity Ratio : 1.613 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.613 |
| September 30, 2025 | 1.922 |
| June 30, 2025 | 2.170 |
| March 31, 2025 | 2.291 |
| December 31, 2024 | 2.286 |
| September 30, 2024 | 2.487 |
| June 30, 2024 | 3.351 |
| March 31, 2024 | 3.401 |
| December 31, 2023 | 2.779 |
| September 30, 2023 | 3.410 |
| June 30, 2023 | 4.052 |
| March 31, 2023 | 4.407 |
| December 31, 2022 | 3.674 |
| September 30, 2022 | 3.401 |
| June 30, 2022 | 2.601 |
| March 31, 2022 | 1.876 |
| December 31, 2021 | 1.432 |
| September 30, 2021 | 1.167 |
| June 30, 2021 | 2.065 |
| March 31, 2021 | 1.758 |
| December 31, 2020 | 1.542 |
| September 30, 2020 | 1.376 |
| June 30, 2020 | 0.5602 |
| March 31, 2020 | 0.521 |
| December 31, 2019 | 0.4413 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.3745 |
| June 30, 2019 | 0.3133 |
| March 31, 2019 | 0.4593 |
| December 31, 2018 | 0.9383 |
| September 30, 2018 | 0.7758 |
| June 30, 2018 | 0.3016 |
| March 31, 2018 | 0.3197 |
| December 31, 2017 | 0.4661 |
| September 30, 2017 | 0.3945 |
| June 30, 2017 | 0.5964 |
| March 31, 2017 | 0.5047 |
| December 31, 2016 | 0.4297 |
| September 30, 2016 | 0.1962 |
| June 30, 2016 | 0.1953 |
| March 31, 2016 | 0.1236 |
| December 31, 2015 | 0.1196 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.1384 |
| December 31, 2014 | 0.1175 |
| September 30, 2014 | 0.3305 |
| June 30, 2014 | 0.3954 |
| March 31, 2014 | 0.4637 |
| December 31, 2013 | 0.3163 |
| September 30, 2013 | 0.015 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BioMarin Pharmaceutical, Inc. | 0.6672 |
| Insmed, Inc. | 0.9865 |
| Ligand Pharmaceuticals, Inc. | 1.169 |
| PTC Therapeutics, Inc. | -4.212 |
| Establishment Labs Holdings, Inc. | 12.20 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 949.87M |
| Total Liabilities (Quarterly) | 675.63M |
| Shareholders Equity (Quarterly) | 274.24M |
| Current Ratio | 2.843 |
| Net Debt Paydown Yield | 0.01% |